Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 23, 2020

SELL
$12.66 - $58.27 $6,367 - $29,309
-503 Closed
0 $0
Q1 2020

Apr 20, 2020

BUY
$9.31 - $18.26 $4,682 - $9,184
503 New
503 $7,000
Q4 2019

Jan 31, 2020

SELL
$8.93 - $12.41 $9,233 - $12,831
-1,034 Closed
0 $0
Q3 2019

Oct 31, 2019

BUY
$8.8 - $14.5 $9,099 - $14,993
1,034 New
1,034 $11,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $411M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Dorsey Wright & Associates Portfolio

Follow Dorsey Wright & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.